What is ataxia?

Ataxia is a disease related to incoordination and can also lead to difficulties while speaking and disruption of balance. Although the disease generally indicates these problems, all parts of the body can have problems related to ataxia and the disease's effects are not limited to the aforementioned area. To give a brief overview, walking, writing, eating, seeing, and swallowing food can be affected. As a consequence, ataxia is not only related to a disease individually but can be expressed as a group of disorders. Generally, the cause of the disease is stated as damage to the cerebellum but it can be related to damage to other types of neurons or the spinal cord.

General symptoms

Symptoms and their severity can differ from patient to patient. People diagnosed with ataxia cannot walk in a straight line and have higher rates of falling in comparison to their previous state. Swallowing difficulties can lead to choking and coughing. Clumsiness is one of the major symptoms. Ataxia is related to difficulty doing things. Difficulty in controlling eye movements leads to blurred or jumpy vision. Speech can be slurred, tremours can be the case. Exhaustion is another symptom of the disease. Even minor impairments in balance do not significantly alter the patient's quality of life; nevertheless, in cases when symptoms are severe, the patient can find it difficult to do daily duties.

Causes

Sometimes the reason a patient has ataxia depends on genetic factors. Here are the inherited types of ataxia:

• Friedreich ataxia
• Ataxia-telangiectasia
• Niemann-Pick disease
• Wilson’s disease

Excluding genetic reasons, causes of the ataxia can be listed as:

• Brain tumours
• Alcohol intoxication
• Chiari malformation
• Gluten intolerance
• Parkinson’s disease
• Transient ischemic attacks (TIAs)
• Traumatic brain injury (TBI)
• Insufficient levels of methylcobalamin (the active form of B12)
• Inhalation of intoxicants
• Multiple sclerosis
• Infections

Cerebellar ataxia

As stated before, ataxia can happen due to disruption of the cerebellum. This kind of ataxia is called cerebellar ataxia. The disease is well-known for the challenges of gait and balance problems. It may be partially explained by the critical role that the cerebellum plays in aiding lesion repair and in motor learning and adaptation.¹

Common pathways, such as misfolding of proteins, are used by all ataxia genes. Cerebellar ataxia also has disruption for a precise amount of Purkinje cells (a specific neuronal type in the cerebellum).²

Sensory ataxia

According to a study with transgenic mice, sensory ataxia can be caused by neurovascular oxidative stress alone.³

A frequent neurological condition brought on by vestibular, cerebellar, or sensory abnormalities is ataxia. Sensory ataxia is still difficult to diagnose and characterise and is sometimes misdiagnosed as cerebellar ataxia, which causes delays and mistakes in diagnosis.⁴There is just one variation associated with sensory ataxia, p.Arg199Cys. It is critical that neurologists understand this distinctive phenotype.⁵

Anti-CNTN1 IgG4 antibodies have been linked to patients with chronic inflammatory demyelinating polyneuropathy (CIDP) who have sensory ataxia and a propensity for a positive response to corticosteroids Consequently, it could serve as a biomarker for selecting more efficient immunotherapy treatments.⁶

There is a new conditional mouse model that mimics the sensory ataxia and neuropathy associated with familial arthritis (FA), but it advances faster and worsens more quickly. Complete elimination of frataxin in parvalbumin-positive cells is the paradigm. It's interesting to note that proprioceptive neurons may go weeks without protoxin, at which time they become completely inactive. Furthermore, researchers demonstrate that the prompt and thorough recovery of the sensory neuropathy linked to frataxin deficiency made possible by post-symptomatic administration of frataxin-expressing AAV constitutes the preclinical proof of concept for the potential of gene therapy in treating FA neuropathy.⁷

Differences in underlying causes

Ataxias are uncommon. They cover a wide range of hereditary traits in addition to varying rates of illness progression. As such, it might be difficult to precisely diagnose them and differentiate them from other neurodegenerative conditions. If a larger cohort could offer non-clinical validation, the proposed approach's value would be increased and it would be qualified for inclusion into routine clinical practice.⁸

Idiopathic ataxia

Due to its variety and the lack of clear causes, adult progressive ataxia can be difficult to diagnose. Idiopathic(unknown origin) ataxia patients frequently go undiagnosed.⁹ Although ataxia patients' movements were sluggish and irregular, their end-point accuracy was similar to healthy individuals.¹⁰

Management of friedreich ataxia

Friedreich ataxia (FA) is the most common inherited neurodegenerative cerebellar ataxic disorder. For those with FA, physiotherapy is highly recommended in order to improve their motor function results. Cerebellar transcranial direct current stimulation (tDCS) has been demonstrated to be effective in symptom relief by modulating cerebellar excitability. Robotic rehabilitation using Lokomat-Pro is a novel way of treating motor dysfunction in ataxic illnesses. Lokomat-Pro functions by modulating cortical plasticity and the cerebellar-motor correlation.¹⁷

The diagnostic perspective to detect Friedreich Ataxia can be evaluated through investigations via blood panels, EMG,nerve conduction studies (NCS), or MRI brain/ the whole spine and also can be based on the genetic analysis. These are all related to the diagnosis. Now, let us dig into more about the management process of Fridrich’s Ataxia. Firstly, the monitoring aspects always depend on clinical aspects as an asset of health monitoring, these can be listed respectively, such as neurological monitoring, musculoskeletal monitoring, cardiac (ECG included) monitoring, endocrine monitoring such as HbA1c or GTT, and visual (auditory) monitoring. Here are the specialists required to provide the essential care for Friedrich ataxia: genetic counsellor, cardiologist, orthopaedics, ophthalmologists, urologists, psychiatrists, and sleep physicians. Physiotherapy, occupational therapy, speech and language therapy and palliative care are the areas of science beneficial to cope with Friedrich ataxia.¹²

Candidate gene for ataxia

For spastic paraplegia and ataxia, SPTAN1 appears to be a promising candidate gene. Scientists suggest that spectrin helices interlinking disruption might be a significant part of the pathomechanism underlying the mutations observed in this investigation.¹³

Ataxia-telangiectasia (A-T)

Although variants can manifest in several ways, neurological symptoms are the most prevalent presenting features in normal A-T cases. Scientists found that most individuals with A-T only reach their adolescent or young adult years. As might be predicted, the most often documented neuropathological outcome was cerebellar atrophy. While numerous studies indicated mild, moderate, or severe cerebellar atrophy, none offered a uniform classification, making it difficult to incorporate the data. The literature contained scant information about EMG/nerve conduction studies.¹⁴

To summarise, immunodeficiency, increasing respiratory failure, cerebellar ataxia, oculocutaneous telangiectasia, and an increased risk of cancer are characteristics of ataxia-telangiectasia, an unusual neurological multisystem disorder. It needs specialised care that is tailored to each patient's needs.¹⁵ 

Treatment

There is currently some evidence—albeit not strong—that suggests rehabilitation might assist individuals with cerebellar ataxia to become more adept at maintaining their posture. This is particularly valid for those with degenerative ataxia or multiple sclerosis. Intense rehabilitation programs must include balance and coordination exercises. Although techniques like torso weighting, biofeedback, virtual reality, and treadmill exercises with supported body weight are helpful, further study is required to pinpoint their exact efficacy. Drug testing has only been done for degenerative ataxia, and the results are not particularly promising.¹⁶ Rehabilitation programmes are usually beneficial for those with ataxia, but there are currently no FDA-approved therapies for the illness. Medication for symptoms including stiffness, myoclonus, tremor, and dystonia that might worsen ataxic conditions is available; these subjects are addressed in different sections of this book. Several drugs and treatments can be used to address symptoms like stiffness, pain, fatigue, depression, trouble sleeping, cognitive impairment, and bowel or bladder problems. The use of various medications off-label to address imbalance has also been the subject of much investigation.¹⁷

Summary

Ataxia is a neurological condition characterized by incoordination, balance issues, and difficulties with motor functions like speaking, writing, and swallowing. It can result from cerebellar damage, spinal cord involvement, or other neuronal disruptions. Symptoms vary but often include unsteady walking, clumsiness, slurred speech, tremors, and fatigue. Ataxia can have genetic causes, such as Friedreich ataxia, or be linked to conditions like Parkinson's disease, brain tumours, or alcohol intoxication.

There are two main types of ataxia: Cerebellar ataxia, which results from cerebellum damage, and Sensory ataxia, caused by sensory nerve damage. While cerebellar ataxia affects motor coordination, sensory ataxia impacts the perception of body position, often leading to misdiagnosis. Treatment varies, but rehabilitation and physiotherapy play key roles in improving motor function, with some experimental therapies showing promise. There are no FDA-approved treatments specifically for ataxia, though symptom management is possible with medications. Genetic research continues to explore potential therapies for inherited forms like Friedreich ataxia.